[1]
|
Cruz-Jentoft, A.J. and Sayer, A.A. (2019) Sarcopenia. The Lancet, 393, 2636-2646.
https://doi.org/10.1016/S0140-6736(19)31138-9
|
[2]
|
Rosenberg, I.H. (1997) Sarcopenia: Origins and Clinical Relevance. The Journal of Nutrition, 127, 990S-991S.
https://doi.org/10.1093/jn/127.5.990S
|
[3]
|
Cruz-Jentoft, A.J., Baeyens, J.P. and Bauer, J.M. (2010) Sarcopenia: European Consensus on Definition and Diagnosis: Report of the European Working Group on Sarcopenia in Older Peo-ple. Age Ageing, 39, 412-423.
https://doi.org/10.1093/ageing/afq034
|
[4]
|
Chen, L.K., Liu, L.K. and Woo, J. (2014) Sarcopenia in Asia: Consen-sus Report of the Asian Working Group for Sarcopenia. Journal of the American Medical Directors Association, 15, 95-101.
https://doi.org/10.1016/j.jamda.2013.11.025
|
[5]
|
Cruz-Jentoft, A.J., Bahat, G. and Bauer, J. (2019) Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age Ageing, 48, 16-31. https://doi.org/10.1093/ageing/afy169
|
[6]
|
Chen, L.K., Woo, J. and Assantachai, P. (2020) Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Di-rectors Association, 21, 300-307.e2.
https://doi.org/10.1016/j.jamda.2019.12.012
|
[7]
|
Anker, S.D., Morley, J.E. and von Haehling, S. (2016) Welcome to the ICD-10 Code for Sarcopenia. Journal of Cachexia, Sarcopenia and Muscle, 7, 512-514. https://doi.org/10.1002/jcsm.12147
|
[8]
|
刘娟, 丁清清, 周白瑜. 中国老年人肌少症诊疗专家共识(2021) [J]. 中华老年医学杂志, 2021, 40(8): 943-952.
https://doi.org/10.3760/cma.j.issn.0254-9026.2021.08.001
|
[9]
|
Mayhew, A.J., Amog, K. and Phillips, S. (2019) The Prevalence of Sarcopenia in Community-Dwelling Older Adults, an Exploration of Differences between Studies and within Definitions: A Systematic Review and Meta-Analyses. Age Ageing, 48, 48-56. https://doi.org/10.1093/ageing/afy106
|
[10]
|
Bischoff-Ferrari, H.A., Orav, J.E., Kanis, J.A. and Rizzoli, R. (2015) Comparative Performance of Current Definitions of Sarcopenia against the Prospective Incidence of Falls among Com-munity-Dwelling Seniors Age 65 and Older. Osteoporosis International, 26, 2793-2802. https://doi.org/10.1007/s00198-015-3194-y
|
[11]
|
Xin, C., Sun, X. and Lu, L. (2021) Prevalence of Sarcopenia in Older Chinese Adults: A Systematic Review and Meta-Analysis. BMJ Open, 11, e041879. https://doi.org/10.1136/bmjopen-2020-041879
|
[12]
|
Makizako, H., Nakai, Y. and Tomioka, K. (2019) Prevalence of Sarcopenia Defined Using the Asia Working Group for Sarcopenia Criteria in Japanese Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. Physical Therapy Research, 22, 53-57. https://doi.org/10.1298/ptr.R0005
|
[13]
|
Choo, Y.J. and Chang, M.C. (2021) Prevalence of Sarcopenia among the Elderly in Korea: A Meta-Analysis. Journal of Preventive Medicine and Public Health, 54, 96-102. https://doi.org/10.3961/jpmph.21.046
|
[14]
|
Pamoukdjian, F., Bouillet, T. and Levy, V. (2018) Prevalence and Pre-dictive Value of Pre-Therapeutic Sarcopenia in Cancer Patients: A Systematic Review. Clinical Nutrition, 37, 1101-1113. https://doi.org/10.1016/j.clnu.2017.07.010
|
[15]
|
Goodman, C.A. (2014) The Role of mTORC1 in Regulating Pro-tein Synthesis and Skeletal Muscle Mass in Response to Various Mechanical Stimuli. Reviews of Physiology, Biochemis-try and Pharmacology, 166, 43-95.
https://doi.org/10.1007/112_2013_17
|
[16]
|
Bano, G., Trevisan, C. and Carraro, S. (2017) Inflammation and Sarco-penia: A Systematic Review and Meta-Analysis. Maturitas, 96, 10-15. https://doi.org/10.1016/j.maturitas.2016.11.006
|
[17]
|
Ebadi, M., Bhanji, R.A. and Mazurak, V.C. (2019) Sarcopenia in Cirrhosis: From Pathogenesis to Interventions. Journal of Gastroenterology, 54, 845-859. https://doi.org/10.1007/s00535-019-01605-6
|
[18]
|
Nardone, O.M., de Sire, R. and Petito, V. (2021) Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure. Frontiers in Immunology, 12, Article ID: 694217.
https://doi.org/10.3389/fimmu.2021.694217
|
[19]
|
Marzetti, E., Calvani, R. and Cesari, M. (2013) Mitochondrial Dysfunction and Sarcopenia of Aging: From Signaling Pathways to Clinical Trials. The International Journal of Bio-chemistry & Cell Biology, 45, 2288-2301.
https://doi.org/10.1016/j.biocel.2013.06.024
|
[20]
|
Lee, H.K., Rocnik, E. and Fu, Q. (2012) Foxo/Atrogin Induction in Human and Experimental Myositis. Neurobiology of Disease, 46, 463-475. https://doi.org/10.1016/j.nbd.2012.02.011
|
[21]
|
Dimitriadis, G., Mitrou, P., Lambadiari, V., et al. (2011) Insulin Effects in Muscle and Adipose Tissue. Diabetes Research and Clinical Practice, 93, S52-S59. https://doi.org/10.1016/S0168-8227(11)70014-6
|
[22]
|
Mirzoev, T.M. and Shenkman, B.S. (2018) Regulation of Protein Synthesis in Inactivated Skeletal Muscle: Signal Inputs, Protein Kinase Cascades, and Ribosome Biogenesis. Bi-ochemistry (Mosc), 83, 1299-1317.
https://doi.org/10.1134/S0006297918110020
|
[23]
|
Shin, M.J., Jeon, Y.K. and Kim, I.J. (2018) Testosterone and Sarcopenia. The World Journal of Men’s Health, 36, 192-198. https://doi.org/10.5534/wjmh.180001
|
[24]
|
Remelli, F., Vitali, A. and Zurlo, A. (2019) Vitamin D Deficiency and Sarcopenia in Older Persons. Nutrients, 11, Article No. 2861. https://doi.org/10.3390/nu11122861
|
[25]
|
Dzik, K.P. and Kaczor, J.J. (2019) Mechanisms of Vitamin D on Skeletal Muscle Function: Oxidative Stress, Energy Metabolism and Anabolic State. European Journal of Applied Physi-ology, 119, 825-839.
https://doi.org/10.1007/s00421-019-04104-x
|
[26]
|
Clynes, M.A., Gregson, C.L. and Bruyere, O. (2021) Osteosar-copenia: Where Osteoporosis and Sarcopenia Collide. Rheumatology (Oxford), 60, 529-537. https://doi.org/10.1093/rheumatology/keaa755
|
[27]
|
Reiss, J., Iglseder, B. and Alzner, R. (2019) Sarcopenia and Osteoporosis Are Interrelated in Geriatric Inpatients. Zeitschrift für Gerontologie und Geriatrie, 52, 688-693. https://doi.org/10.1007/s00391-019-01553-z
|
[28]
|
Locquet, M., Beaudart, C. and Reginster, J.Y. (2019) Associa-tion between the Decline in Muscle Health and the Decline in Bone Health in Older Individuals from the SarcoPhAge Cohort. Calcified Tissue International, 104, 273-284.
https://doi.org/10.1007/s00223-018-0503-4
|
[29]
|
Da Silva, A.P., Matos, A. and Ribeiro, R. (2017) Sarcopenia and Osteoporosis in Portuguese Centenarians. European Journal of Clinical Nutrition, 71, 56-63. https://doi.org/10.1038/ejcn.2016.174
|
[30]
|
Kirk, B., Zanker, J. and Duque, G. (2020) Osteosarcopenia: Epidemiol-ogy, Diagnosis, and Treatment-Facts and Numbers. Journal of Cachexia, Sarcopenia and Muscle, 11, 609-618. https://doi.org/10.1002/jcsm.12567
|
[31]
|
Dos Santos, Pinto, D. and Kloeckner, R. (2020) Sarcopenia as Prognostic Factor for Survival after Orthotopic Liver Transplantation. European Journal of Gastroenterology & Hepatology, 32, 626-634.
https://doi.org/10.1097/MEG.0000000000001552
|
[32]
|
Tantai, X., Liu, Y. and Yeo, Y.H. (2022) Effect of Sarco-penia on Survival in Patients with Cirrhosis: A Meta-Analysis. Journal of Hepatology, 76, 588-599. https://doi.org/10.1016/j.jhep.2021.11.006
|
[33]
|
Sinclair, M., Gow, P.J. and Grossmann, M. (2016) Review Article: Sarcopenia in Cirrhosis—Aetiology, Implications and Potential Therapeutic Interventions. Alimentary Pharmacology & Therapeutics, 43, 765-777.
https://doi.org/10.1111/apt.13549
|
[34]
|
Ebadi, M., Bhanji, R.A. and Mazurak, V.C. (2019) Sarcopenia in Cirrhosis: From Pathogenesis to Interventions. Journal of Gastroenterology, 54, 845-859. https://doi.org/10.1007/s00535-019-01605-6
|
[35]
|
Ryan, E., McNicholas, D. and Creavin, B. (2019) Sarcopenia and Inflammatory Bowel Disease: A Systematic Review. Inflammatory Bowel Diseases, 25, 67-73. https://doi.org/10.1093/ibd/izy212
|
[36]
|
Jeejeebhoy, K.N. and Duerksen, D.R. (2018) Malnutrition in Gastrointesti-nal Disorders: Detection and Nutritional Assessment. Gastroenterology Clinics of North America, 47, 1-22. https://doi.org/10.1016/j.gtc.2017.09.002
|
[37]
|
Balestrieri, P., Ribolsi, M., Guarino, M.P.L. and Emerenziani, S. (2020) Nutritional Aspects in Inflammatory Bowel Diseases. Nutrients, 12, 372. https://doi.org/10.3390/nu12020372
|
[38]
|
Ticinesi, A., Mancabelli, L. and Tagliaferri, S. (2020) The Gut-Muscle Axis in Older Subjects with Low Muscle Mass and Performance: A Proof of Concept Study Exploring Fecal Microbiota Composition and Function with Shotgun Metagenomics Sequencing. International Journal of Molecular Sciences, 21, 8946. https://doi.org/10.3390/ijms21238946
|
[39]
|
Liu, S., Ding, X. and Maggiore, G. (2022) Sarcopenia Is Associ-ated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Cohort Study. Annals of Translational Medicine, 10, 367.
https://doi.org/10.21037/atm-22-1126
|
[40]
|
Anagnostis, P., Gkekas, N.K. and Achilla, C. (2020) Type 2 Diabetes Mellitus Is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-Analysis. Calcified Tissue In-ternational, 107, 453-463.
https://doi.org/10.1007/s00223-020-00742-y
|
[41]
|
Mori, H., Kuroda, A. and Ishizu, M. (2019) Association of Ac-cumulated Advanced Glycation End-Products with a High Prevalence of Sarcopenia and Dynapenia in Patients with Type 2 Diabetes. Journal of Diabetes Investigation, 10, 1332-1340. https://doi.org/10.1111/jdi.13014
|
[42]
|
Sugimoto, K., Ikegami, H. and Takata, Y. (2021) Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Dia-betes: The MUSCLES-DM Study. Journal of the American Medical Directors Association, 22, 834-838. e1. https://doi.org/10.1016/j.jamda.2020.11.003
|
[43]
|
Narasimhulu, Aluganti, C. and Singla, D.K. (2021) Amelioration of Diabetes-Induced Inflammation Mediated Pyroptosis, Sarcopenia, and Adverse Muscle Remodelling by Bone Mor-phogenetic Protein-7. Journal of Cachexia, Sarcopenia and Muscle, 12, 403-420. https://doi.org/10.1002/jcsm.12662
|
[44]
|
Tsekoura, M., Tsepis, E. and Billi, E. (2020) Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease: A Study of Prevalence and Associated Factors in Western Greek Population. Lung India, 37, 479-484.
https://doi.org/10.4103/lungindia.lungindia_143_20
|
[45]
|
Sepulveda-Loyola, W., Osadnik, C. and Phu, S. (2020) Diagnosis, Prevalence, and Clinical Impact of Sarcopenia in COPD: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle, 11, 1164-1176.
https://doi.org/10.1002/jcsm.12600
|
[46]
|
Ito, A., Hashimoto, M. and Tanihata, J. (2022) Involvement of Par-kin-Mediated Mitophagy in the Pathogenesis of Chronic Obstructive Pulmonary Disease-Related Sarcopenia. Journal of Cachexia, Sarcopenia and Muscle, 13, 1864-1882.
https://doi.org/10.1002/jcsm.12988
|
[47]
|
Van Bakel, S.I.J., Gosker, H.R., Langen, R.C. and Schols, A.M.W.J. (2021) Towards Personalized Management of Sarcopenia in COPD. International Journal of Chronic Obstructive Pul-monary Disease, 16, 25-40.
https://doi.org/10.2147/COPD.S280540
|
[48]
|
Sancho-Munoz, A., Guitart, M. and Rodriguez, D.A. (2021) Defi-cient Muscle Regeneration Potential in Sarcopenic COPD Patients: Role of Satellite Cells. Journal of Cellular Physiology, 236, 3083-3098.
https://doi.org/10.1002/jcp.30073
|
[49]
|
Warnken-Miralles, M.D., Lopez-Garcia, F. and Zamora-Molina, L. (2021) Sarcopenia Index in Hospitalized Patients with Chronic Obstructive Pulmonary Disease Exacerbation. Medicina (B Aires), 81, 323-328.
|
[50]
|
Kashani, K.B., Frazee, E.N. and Kukralova, L. (2017) Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index. Critical Care Medicine, 45, e23-e29.
https://doi.org/10.1097/CCM.0000000000002013
|
[51]
|
Wu, Y.K., Li, M. and Zhang, Y.C. (2022) The Sarcopenia Index Is an Effective Predictor for Malnutrition in Patients with Liver Cirrhosis. Nutrition & Dietetics, 79, 563-571. https://doi.org/10.1111/1747-0080.12738
|
[52]
|
Zhao, X., Su, R. and Hu, R. (2023) Sarcopenia Index as a Predictor of Clinical Outcomes among Older Adult Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. BMC Geriatrics, 23, Article No. 89. https://doi.org/10.1186/s12877-023-03784-7
|
[53]
|
Ge, J., Zeng, J. and Ma, H. (2022) A New Index Based on Se-rum Creatinine and Cystatin C Can Predict the Risks of Sarcopenia, Falls and Fractures in Old Patients with Low Bone Mineral Density. Nutrients, 14, 5020.
https://doi.org/10.3390/nu14235020
|
[54]
|
Tang, T., Xie, L. and Hu, S. (2022) Serum Creatinine and Cystatin C-Based Diagnostic Indices for Sarcopenia in Advanced Non-Small Cell Lung Cancer. Journal of Cachexia, Sarcopenia and Muscle, 13, 1800-1810.
https://doi.org/10.1002/jcsm.12977
|
[55]
|
Zheng, C., Wang, E. and Li, J.S. (2022) Serum Creatinine/Cystatin C Ratio as a Screening Tool for Sarcopenia and Prognostic Indicator for Patients with Esophageal Cancer. BMC Geriatrics, 22, Article No. 207.
https://doi.org/10.1186/s12877-022-02925-8
|
[56]
|
Xu, X., Chen, Y. and Cai, W. (2023) A Multivariable Model Based on Ultrasound Imaging Features of Gastrocnemius Muscle to Identify Patients with Sarcopenia. Journal of Ultra-sound in Medicine. https://doi.org/10.1002/jum.16223
|
[57]
|
Zhu, K., Wactawski-Wende, J. and Ochs-Balcom, H.M. (2021) The Association of Muscle Mass Measured by D3-Creatine Dilution Method with Dual-Energy X-Ray Absorp-tiometry and Physical Function in Postmenopausal Women. The Journals of Gerontology Series A Biological Sciences and Medical Sciences, 76, 1591-1599.
https://doi.org/10.1093/gerona/glab020
|